New Delhi, 24 September, 2025: The debate around paracetamol (acetaminophen) use during pregnancy has intensified after recent public statements by former US President Donald Trump, who claimed a causative link between prenatal use of Tylenol and autism in children. Trump’s assertions triggered strong backlash from health authorities worldwide, including a clear pushback from the World Health Organization (WHO), which reiterated that no established scientific link exists.
In the midst of this controversy, doctors like Dr. Abha Majumdar, Senior Consultant in Obstetrics & Gynecology, have emphasized that while some observational studies hint at potential neurodevelopmental effects, the evidence is inconsistent and inconclusive. This article examines Trump’s claims, WHO’s response, what current science says, and the practical precautions pregnant women should consider.
Trump’s Claims: Paracetamol, Autism & Vaccines
At a press conference, Donald Trump asserted that the “meteoric rise” in autism diagnoses is partly due to widespread use of Tylenol (acetaminophen) during pregnancy. He advised expectant mothers to avoid taking Tylenol unless absolutely necessary, suggesting the drug might artificially induce autism. He also linked vaccines and Tylenol together in promoting autism risk—an allegation that revived old myths about vaccine safety.
These claims are particularly significant because they came from a high-profile political figure, amplifying public concern and prompting calls for immediate investigation. However, several health experts and regulatory bodies quickly labeled the claims as lacking scientific basis and potentially dangerous if they dissuade pregnant women from necessary fever and pain relief.
WHO Steps In: Rejects Claims, Warns Against Delaying Immunization
In response to growing confusion and fear, the World Health Organization (WHO) issued a statement clarifying that there is no conclusive scientific evidence that links paracetamol or vaccines to autism. They stressed that vaccines are among the most reliable tools for preventing disease and saving lives, and warned that misinformation that discourages immunization could lead to serious public health consequences.
WHO stated that the evidence regarding paracetamol use in pregnancy and neurodevelopmental disorders such as autism is inconsistent. Some studies show correlations, but correlation does not prove causation. They urged that current medical guidelines remain valid while further research is pursued.
In effect, WHO’s intervention served to reassure pregnant women, healthcare providers, and regulatory agencies that existing recommendations about safe paracetamol use during pregnancy should continue, and that fear-based changes in behavior should be avoided.
What the Scientific Research Shows
Observational Studies & Their Limitations
Multiple epidemiological studies across different populations have explored associations between frequent or high-dose paracetamol use during pregnancy and increased risks of autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD) in offspring. Some have found weak to moderate positive associations; others have found no significant link.
However, there are major limitations:
- Confounding factors: Often, women who use paracetamol frequently may have underlying conditions (fever, infection, inflammation) that themselves carry risk for neurodevelopmental outcomes.
- Reverse causality or bias: The reason for paracetamol use (e.g. chronic pain or inflammation) might be a contributing factor, not the drug itself.
- Lack of randomized controlled trials (RCTs): Because it would be unethical to randomize pregnant women to take or avoid paracetamol, causality remains difficult to establish.
Dr. Abha Majumdar frames the issue carefully: “There have been multiple observational studies … that show that very frequent use of Tylenol in pregnancy may have some negative effects on the neurodevelopment of the fetus. However … we do not know whether it is due to the underlying condition, genetic predisposition, or environmental factors.”
She also points out the practical dilemma faced by expecting mothers: paracetamol remains one of the few relatively safe options when other pain medications (e.g. NSAIDs) are contraindicated, especially after the 20th week of gestation. Dr. Majumdar’s balanced stance is that while we should remain open to new evidence, we must also avoid causing fear that might lead to untreated fevers or pain—both of which carry risks for the fetus.
The Risks of Overreaction
If Trump’s claims are accepted without scrutiny, they pose several risks:
- Pregnant women might avoid necessary treatment for fever or pain, which can itself endanger fetal development, lead to dehydration, or increase maternal stress.
- Misinformation could lead to vaccine hesitancy, especially when claims about Tylenol and vaccines are lumped together, undermining public trust in immunization.
- Public anxiety can grow, placing undue guilt on mothers who used paracetamol during pregnancy under medical guidance.
Thus, the medical community emphasizes that fear-based responses must not replace evidence-based guidelines.
What Pregnant Women Should Do
Given the ambiguity of evidence and the importance of maternal health, experts generally advise:
- Use paracetamol only when necessary, not as a default for mild discomfort.
- Take the lowest effective dose for the shortest possible duration.
- Avoid frequent, prolonged use unless medically advised.
- Ensure underlying conditions (fever, infection, pain) are properly managed under medical supervision.
- Consult a doctor before taking any medication, even over-the-counter.
This balanced approach aims to mitigate potential risk without compromising maternal or fetal health.
The Path Forward: What Research Needs to Address
To resolve this debate, researchers must:
- Conduct large-scale, well-controlled cohort studies that adjust for confounding variables.
- Develop more precise biomarkers for fetal exposure and neurodevelopmental outcomes.
- Explore dose thresholds (is there a safe upper limit?)
- Reinforce long-term follow-up studies in children exposed prenatally.
Until then, medical authorities and health organizations will likely adhere to existing guidelines but encourage transparency and caution in messaging.
Donald Trump’s claim that paracetamol use in pregnancy causes autism sparked alarm across medical, scientific, and public health communities. While he presented the idea with certainty, the World Health Organization swiftly and publicly debunked it, confirming that vaccines do not cause autism and that the link between paracetamol and autism remains scientifically unsupported.
Experts like Dr. Abha Majumdar emphasize that while observational studies raise questions, they do not establish causation. Pregnant women should not be terrified into inaction—untreated fever or pain can themselves pose risks. Instead, they should follow guidance: use medications judiciously, seek medical advice, and stay informed.
At this crossroads of politics, health, and misinformation, the best defense remains evidence, expert guidance, and cautious pragmatism. The conversation has value—not to stoke fear, but to encourage scientific rigor, better research, and safe care for mothers and babies alike.
